Luvo Health review

Take a low dose here and it genuinely costs you less. Luvo runs microdosing as its own program with three named products — two injections and an oral tablet — priced well under the standard semaglutide injection, and it publishes both figures on the same table so the saving can be checked rather than taken on faith. It counts in weeks throughout instead of quietly calling four weeks a month, and its year-long rung really is fifty-two weeks. Two things will cost you if you misread them. The microdosing plans stop at twelve weeks: the twenty-four and fifty-two week rungs, where the discounts are deepest, are sold only on standard doses, so committing longer means moving up. And the weekly figure headlined on a microdosing product is the twelve-week rate, not the month-to-month one. No milligram figure sits behind any of it, so microdosing here is a tier rather than a stated amount.

Vs median

Not comparable — billed per four weeks, which is thirteen charges a year rather than twelve, so it is not a monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Prices the low dose on its own

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Luvo Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Luvo Health sells compounded semaglutide and tirzepatide as injections and semaglutide as an oral tablet, and runs microdosing as a separate program with its own navigation entry, its own pricing tab and three named products. Everything is priced in blocks of four, twelve, twenty-four and fifty-two weeks, and the whole matrix is public rather than held behind an intake. It displays a LegitScript seal number, tells patients they may fill a prescription at any licensed pharmacy, and warns that prices can change with supply costs or promotions. It names no compounding pharmacy and does not publish the states it serves.

THE MICRODOSING PLANS STOP AT 12 WEEKS. There is no 24-week or 52-week microdosing rung, so the deepest prepay discounts are available only if you buy a standard dose

• NO MILLIGRAM FIGURE SITS BEHIND ANY RUNG, microdosing included — "depends on your dose" is delivered as two tiers rather than a dose ladder, so what the $179 buys is not stated
• The "Starting at $42/week" headline on a microdosing product is the 12-week rung; the month-to-month rate works out at $44.75 a week
• The compounding pharmacy is not named
• The states served are not published — availability is deferred to onboarding
• Prices are not locked: "Prices can change due to plan changes, medication selection, supply costs, or promotions ending"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Luvo Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan